Free Cash Flow Build Up
NeuBase Therapeutics, Inc. (NBSE)
$0.172
-0.02 (-8.99%)
Year A/P |
| Revenue |
|---|
| EBITDA |
| EBIT |
| Tax Rate |
| EBIAT |
| Depreciation |
| Accounts Receivable |
| Inventories |
| Accounts Payable |
| Capital Expenditure |
| UFCF |
| WACC |
| PV UFCF |
| SUM PV UFCF |